Publication | Open Access

Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow—a long-term follow-up

Surgical OncologyOncologyLong-term Follow-upBreast OncologyCancer ManagementPharmacologyBreast CancerCancer TreatmentMedicineOverall SurvivalAdjuvant Oral Clodronate